1473PFirst-line ceritinib versus chemotherapy in patients (pts) with advanced ALK rearranged (ALK+) non-small cell lung cancer (NSCLC): ASCEND-4 Asian subgroup analysis

D S Tan,S Geater,C J Yu,C M Tsai,T C Hsia, J Zhou, J Chen,M C Lin,P Yu, J He, W Li, Y Lu,V Sriuranpong, C T Yang, P Sen,F Branle,M Shi,Y L Wu

ANNALS OF ONCOLOGY(2019)

Cited 2|Views27
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined